SS
Sukhvinder Singh Kandiala
About Sukhvinder Singh Kandiala
Data last updated:
Sukhvinder Singh Kandiala is an Additional Director at Dapcure Pharmaceutical Private Limited (since 2022) and Director at Mapsn Drug Private Limited (since 2020). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Dapcure Pharmaceutical Private Limited at ₹2.1 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 17 Aug 2022 | 2020 | ₹2.1 Lakh (FY 2022) | Active | |
| Director | 01 Dec 2020 | 2020 | Active |
Board colleagues of Sukhvinder Singh Kandiala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Daphne Kaur Kandiala | 08700593 | Dapcure Pharmaceutical Private Limited , Mapsn Drug Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sukhvinder Singh Kandiala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sukhvinder Singh Kandiala
Sukhvinder Singh Kandiala currently holds 2 directorships: Dapcure Pharmaceutical Private Limited (Additional Director, since 17 Aug 2022, revenue ₹2.1 Lakh (FY 2022)); Mapsn Drug Private Limited (Director, since 01 Dec 2020).
Sukhvinder Singh Kandiala was first appointed on 01 Dec 2020 as Director at Mapsn Drug Private Limited. The most recent appointment on record is 17 Aug 2022 at Dapcure Pharmaceutical Private Limited.
The current boards of Sukhvinder Singh Kandiala's companies include Daphne Kaur Kandiala (Dapcure Pharmaceutical Private Limited).